Amgen Industry Symposium
Managing multiple myeloma at first relapse: Emerging treatment paradigms
Sunday, May 9, 2021 – 12:20-13:30 CEST
Thomas Martin, MD
Clinical Professor of Medicine, Adult Leukemia and Bone Marrow Transplantation Program
Associate Director, Myeloma Program, UCSF
Co-Leader, Cancer Immunology & Immunotherapy Program,
Helen Diller Family Comprehensive Cancer Center
AGENDA:
| 12:20-13:10 | Managing multiple myeloma at first relapse: Emerging treatment paradigms Thomas Martin, MD |
| 13:10-13:30 | Q&A |